The MedTek21 Partner Network consists of clinical and technology leaders who share a commitment to dramatically improving patient care through personalized medication management.

AccessDX Laboratory is a CLIA-certified and CAP-accredited diagnostic laboratory dedicated to providing clinical insights that improve patient outcomes. AccessDX diagnostic solutions include pharmacogenomic (PGX) testing, cancer genomic (CGX) testing, respiratory pathogen panels, and a wide range of other clinical laboratory services. AccessDX diagnostics are currently trusted by thousands of clinical providers in health systems nationwide. For more visit

Translational Software™ empowers physicians to make the most effective treatment decisions using actionable genetic intelligence. The company’s proprietary pharmacogenomics platform and API provide genetic information and reporting at the point of care to alert physicians to potential drug-gene interactions, adverse drug events, and the best medication alternatives for personalized medicine. For more visit

Health Level Seven International (HL7) is a not-for-profit, ANSI-accredited standards developing organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information. MedTek21 is an HL7 International Gold Member, and incorporates the usage ot HL/7 messaging and FHIR technology to ensure seamless operation with existing EMR, EHR, pharmacy, and third-party analytics platforms. For more, visit

MedTek21 is a proud partner of Verizon Wireless. In addition to providing local and regional education on the benefits of personalized medication management, the Verizon teams work with MedTek21 to seamlessly support the on-demand connectivity needs of both facilities and remote clinicians.